Seoul, South Korea

Eui Hyun Kim

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Eui Hyun Kim: Pioneering Cancer Treatment

Introduction: Eui Hyun Kim, an esteemed inventor based in Seoul, South Korea, has significantly contributed to the field of cancer research through his innovative work. With a focus on pharmaceutical compositions aimed at combating cancer stem cells, Kim's efforts are paving the way for new treatment options.

Latest Patents: Eui Hyun Kim holds a patent for a pharmaceutical composition designed to inhibit the growth of cancer stem cells. This invention specifically combines an aldehyde inhibitor with a biguanide-based compound. The formulation shows promising results in not only inhibiting the growth of neurospheres but also in preventing the proliferation, invasion, and metastasis of cancer cells, particularly in cases of brain cancer.

Career Highlights: Currently associated with the National Cancer Center, Eui Hyun Kim's work is making a remarkable impact in the medical field. His dedication to finding effective cancer treatments reflects his commitment to improving patient outcomes and advancing scientific knowledge.

Collaborations: Throughout his career, Kim has collaborated with notable colleagues, including Seok Gu Kang and Jong Hee Chang. These collaborations enhance the breadth and depth of research at the National Cancer Center, fostering an environment of innovation and shared expertise.

Conclusion: Eui Hyun Kim stands as a testament to the power of innovation in medicine. His patent for a pharmaceutical composition signifies a crucial step towards more effective cancer treatments, showcasing the vital role inventors play in addressing some of the world’s most pressing health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…